Royalty Pharma RPRX
NASDAQ RPRX
$69.31 +0.34 (+0.49%)
At close: Nov 13, 2026 · 4:00 PM EST

Royalty Pharma (RPRX) Return on Sales [ROS] (2019 - 2026)

Updated

Royalty Pharma (RPRX) reported Return on Sales [ROS] of 59.53% for Q3 2026, down 10.57 percentage points from 70.11% a year earlier but up 39.79 percentage points from the prior quarter.

Analysis

Royalty Pharma (RPRX) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Royalty Pharma's Return on Sales [ROS] came in at 57.14%, down 8.08 percentage points year-over-year; for FY2025, it came in at 65.58%, up 8.48 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -9.60 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at 57.10% in FY2024 (-6.28 pp), 63.37% in FY2023 (+49.65 pp), 13.73% in FY2022 (-48.77 pp) and 62.49% in FY2021 (-12.68 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -85.31% in Q4 2022 and a high of 130.17% in Q3 2024.
  • Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of -4.90 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q4 2023 (a gain of 188.14 percentage points); the low point was Q4 2022 (a drop of 111.96 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at 19.75% (Q2 2026), 89.29% (Q1 2026) and 62.44% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Royalty Pharma 39.80 Bn 40.13 Bn - 59.53%
2 Rocket Companies 38.90 Bn 27.72 Bn - 40.10%
3 Orix 38.66 Bn 9.30 Bn 13.83 Bn 4.59%
4 Federal National Mortgage Association Fannie Mae 26.46 Bn -16,107.65 Bn - 467.76%
5 Synchrony Financial 22.47 Bn -45.15 Bn - 43.96%
6 Affirm Holdings 22.07 Bn 15.11 Bn - 14.82%
7 Royal Gold 21.71 Bn 20.92 Bn 402.46 Mn 65.35%
8 Ares Capital 13.84 Bn 11.59 Bn - -
9 Annaly Capital Management 13.83 Bn 4.86 Bn - 51.56%
10 Federal Home Loan Mortgage 12.64 Bn -328.33 Bn - 487.58%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 59.53%
Jun 30, 2026 19.75%
Mar 31, 2026 89.29%
Dec 31, 2025 62.44%
Sep 30, 2025 70.11%
Jun 30, 2025 36.26%
Mar 31, 2025 94.01%
Dec 31, 2024 60.90%
Sep 30, 2024 130.17%
Jun 30, 2024 50.19%
Mar 31, 2024 -12.99%
Dec 31, 2023 102.82%
Sep 30, 2023 28.24%
Jun 30, 2023 46.24%
Mar 31, 2023 70.03%
Dec 31, 2022 -85.31%
Sep 30, 2022 33.52%
Jun 30, 2022 70.49%
Mar 31, 2022 39.09%
Dec 31, 2021 26.65%
API Access

Royalty Pharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RPRX&period=max&api_key=YOUR_API_KEY